unknown
Stage
1
Investors
About
WARD 24/7 develops a clinically validated software platform that continuously monitors hospital patients' vital signs using wireless sensors and advanced algorithms to detect clinical deterioration earlier and support healthcare professionals in preventing complications.
Explore WARD 24/7's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.